TMEM69, transmembrane protein 69, emerges as a critical component within the cellular architecture, contributing significantly to the intricate landscape of cellular physiology. Its precise role, while not fully delineated, hints at involvement in essential cellular processes such as signal transduction, membrane dynamics, and the regulation of intracellular trafficking. As a transmembrane entity, TMEM69 is poised to act as a mediator in the communication between the intracellular and extracellular environments, facilitating the transduction of signals across the cellular membrane. This positioning allows it to influence a myriad of cellular functions, ranging from growth and proliferation to apoptosis and differentiation. By modulating the availability and activity of various signaling molecules and receptors, TMEM69 indirectly shapes the cellular response to external cues, maintaining cellular homeostasis and adapting to environmental changes.
The activation of TMEM69 is a complex process, governed by multiple layers of regulation, including transcriptional, translational, and post-translational modifications (PTMs). On the transcriptional level, the expression of TMEM69 could be modulated by specific transcription factors responding to cellular stimuli, thus integrating TMEM69 into broader signaling networks. Post-transcriptionally, mechanisms such as alternative splicing may generate diverse TMEM69 isoforms with distinct functions or regulatory properties, expanding its functional repertoire. Post-translationally, TMEM69 activity can be modulated through various PTMs, including phosphorylation, glycosylation, or palmitoylation, which could affect its membrane localization, stability, or interaction with other proteins. Such modifications allow TMEM69 to dynamically respond to changes in the cellular environment, enabling precise control over its functional activity. These regulatory mechanisms underscore the complexity of TMEM69's role within the cell and highlight the sophistication of cellular systems in orchestrating physiological processes through the modulation of transmembrane protein function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin is a potent activator of adenylyl cyclase, an enzyme that increases the levels of cyclic adenosine monophosphate (cAMP) in cells. The elevated cAMP levels can activate protein kinase A (PKA), which can phosphorylate and activate TMEM69. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing the degradation of cAMP and therefore indirectly enhancing the activity of TMEM69 via the PKA pathway. | ||||||
Uridine-5′-triphosphate, Trisodium Salt | 19817-92-6 | sc-301964 sc-301964A | 50 mg 1 g | $86.00 $118.00 | 2 | |
UTP activates P2Y receptors, leading to phospholipase C activation and the production of inositol trisphosphate (IP3) and diacylglycerol (DAG), which can activate TMEM69. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $53.00 | ||
ATP also activates P2Y receptors, leading to the production of IP3 and DAG through the phospholipase C pathway, indirectly enhancing the activity of TMEM69. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $506.00 | |||
Ouabain inhibits the sodium-potassium ATPase pump, leading to an increase in intracellular calcium levels. The elevated calcium levels can activate TMEM69. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), causing an increase in cytosolic calcium levels. This increase can activate TMEM69. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium concentration, which can activate TMEM69. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $45.00 $60.00 $115.00 $170.00 $520.00 | 36 | |
Glyburide inhibits ATP-sensitive K+ channels, resulting in membrane depolarization and the opening of voltage-gated calcium channels, which can enhance the activity of TMEM69. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil is a calcium channel blocker that can modify intracellular calcium levels, indirectly leading to the activation of TMEM69. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
BAPTA-AM is a cell-permeant calcium chelator that can modify intracellular calcium levels, indirectly leading to the activation of TMEM69. |